Australia markets open in 38 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.8300-0.0100 (-0.54%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-28,596
-41,009
875
-6,388
Depreciation & amortisation
1,983
2,333
2,744
3,077
Deferred income taxes
-71
-192
-167
-182
Stock-based compensation
4,395
1,755
1,100
792
Change in working capital
4,073
5,729
-172
4,145
Inventory
-
-877
-4,406
-3,419
Other working capital
-12,918
-6,898
4,547
13,557
Other non-cash items
6,989
24,711
557
6,081
Net cash provided by operating activities
-9,968
-921
13,238
23,755
Cash flows from investing activities
Investments in property, plant and equipment
-2,950
-5,977
-8,691
-10,198
Net cash used for investing activities
24,510
-5,977
-8,691
-10,198
Cash flows from financing activities
Debt repayment
-12,413
-124,014
-2,939
-3,240
Common stock issued
317
25,336
0
0
Common stock repurchased
-
-
-
0
Dividends paid
0
0
0
0
Other financing activities
-989
-5,743
-848
-
Net cash used provided by (used for) financing activities
-15,682
-12,322
-6,019
-2,716
Net change in cash
-1,140
-19,220
-1,472
10,841
Cash at beginning of period
7,254
25,910
27,327
16,400
Cash at end of period
6,114
6,578
25,910
27,327
Free cash flow
Operating cash flow
-9,968
-921
13,238
23,755
Capital expenditure
-2,950
-5,977
-8,691
-10,198
Free cash flow
-12,918
-6,898
4,547
13,557